Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
Reel/Frame: | 059984/0459 | |
| Pages: | 6 |
| | Recorded: | 05/23/2022 | | |
Attorney Dkt #: | 095136-0189, -0637 |
Conveyance: | ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). |
|
Total properties:
1
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
17776860
|
Filing Dt:
|
05/13/2022
|
Publication #:
|
|
Pub Dt:
|
12/08/2022
| | |
PCT #:
|
IB2020060719
|
Title:
|
RENAL CELL CARCINOMA (RCC) THERAPY USING GENETICALLY ENGINEERED T CELLS TARGETING CD70
|
|
Assignee
|
|
|
BAARERSTRASSE 14 |
ZUG, SWITZERLAND 6300 |
|
Correspondence name and address
|
|
MCDERMOTT WILL & EMERY
|
|
200 CLARENDON STREET
|
|
58TH FLOOR
|
|
BOSTON, MA 02116-5021
|
Search Results as of:
09/23/2024 12:57 PM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|